-
-
-
-
-
-
-
Q2 Investor Summit Virtual Live Wednesday June 24
-
-
-
-
-
-
-
bioAffinity (BIAF) Misses Q1 EPS by 81c
-
-
-
-
-
-
-
bioAffinity Technologies reports 111% jump in october lung test volume
-
-
-
-
-
-
-
bioAffinity shares case studies showing CyPath Lung test detected stage 1A cancer
-
-
-
-
-
-
-
bioAffinity (BIAF) Announces New U.S. Patent for Novel Broad Spectrum Cancer Therapeutics
-
-
-
-
-
-
-
bioAffinity (BIAF) Reports Record $9.4M Revenue for 2024
-
-
-
-
-
-
-
bioAffinity (BIAF) Prices 2.05M Share Offering at $1.30/sh
-
456,957 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

